tiviti
host
resist
adopt
transfer
mediat
autoregulatori
popul
thymic
depend
sensit
radiat
cyclophosphamid
cy
lewi
l
femal
rat
corona
viru
free
wk
old
purchas
charl
river
breed
laboratori
wilmington
kept
isol
total
bodi
irradi
tbi
lewi
rat
irradi
day
either
rad
radmin
dualsourc
small
anim
irradi
atom
energi
canada
ltd
kanata
ontario
canada
hemibodi
irradi
lewi
rat
irradi
irradi
j
l
shepard
mark
glendal
ca
collim
beam
attenu
dose
direct
either
thymu
pelvi
estim
rad
cm
collim
beam
without
take
effect
radiat
dose
absorb
cm
interven
tissu
day
transplant
rat
receiv
x
splenocyt
autoimmun
donor
materi
method
cy
lewi
rat
inject
intraperiton
mgkg
cy
meadjohnson
evansvil
day
either
administr
regimen
csa
therapi
adopt
transfer
effector
splenocyt
busulfan
lewi
rat
gavag
mgkg
busulfan
burrough
wellcom
day
prior
initi
induct
sgvhd
adopt
transfer
effector
splenocyt
cy
busulfan
lewi
rat
gavag
mgkg
busulfan
burrough
wellcom
co
greenvil
ny
day
inject
intraperiton
mgkg
cy
day
initi
day
bone
marrow
reconstitut
csa
therapi
induct
phase
donor
viralfre
lewi
rat
kill
asphyxi
marrow
collect
femur
tibia
humeri
rpmi
marrow
cell
adjust
concentr
x
nucleat
cellsml
infus
recipi
anim
intraven
inject
dorsal
tail
vein
day
total
volum
inject
ml
induct
adopt
transfer
studi
requir
induct
sgvhd
rat
treat
immunoabl
therapi
infus
bone
marrow
subcutan
inject
csa
analyz
requir
transfer
diseas
secondari
recipi
either
irradi
treat
immunoabl
therapi
bone
marrow
reconstitut
infus
effector
splenocyt
autoimmun
donor
day
unless
otherwis
indic
effector
splenocyt
harvest
anim
earli
onset
sgvhd
csa
therapi
lethal
irradi
syngen
marrow
transplant
rat
receiv
medic
drink
water
supplement
bactrim
neomycin
polymixin
b
previous
describ
csa
gener
gift
sandoz
ltd
basel
switzerland
powder
csa
dissolv
ethanol
ad
emulphor
solut
deioniz
rat
weigh
daili
receiv
gday
subcutan
day
marrow
infus
consecut
day
total
dose
csa
per
day
per
rat
mgkg
control
anim
receiv
ident
quantiti
drug
diluent
ethanol
emulphor
without
csa
rat
examin
daili
sign
clinic
gvhd
red
ear
alopecia
dermat
diarrhea
ear
skin
biopsi
taken
frequent
interv
previous
describ
criteria
use
histolog
document
acut
chronic
gvhd
murin
mab
direct
rat
lymphocyt
determin
purchas
serotec
bioproduct
scienc
inc
indianapoli
specif
mab
ascit
fluid
use
studi
consist
panspecif
rat
lymphocyt
panspecif
rat
lymphocyt
spleen
cell
normal
anim
fraction
nylon
wool
fenwal
laboratori
deerfield
il
enrich
cell
previous
describ
nonadher
popul
fag
analysi
pan
nylon
woolnonadher
spleen
cell
normal
anim
deplet
lymphocyt
pan
previous
describ
briefli
lymphocyt
incub
h
ml
dilut
pb
place
petri
dish
coat
affinitypurifi
goat
antimous
igg
tago
inc
burlingam
ca
plate
lightli
centrifug
incub
h
nonadher
fraction
aspir
reincub
newli
coat
petri
dish
second
pan
nonadher
fraction
aspir
plate
care
rins
bsapb
solut
popul
analyz
directli
fitcconjug
immunomagnet
separ
nylon
woolnonadher
spleen
cell
normal
anim
separ
lymphocyt
subset
immunomagnet
separ
use
immunomagnet
bead
coat
commerci
coval
bound
affin
purifi
fc
specif
sheep
polyclon
immunoglobulin
mous
subclass
dynabead
dynal
inc
great
neck
ny
previous
describ
briefli
x
cell
incub
satur
concentr
ofprimari
antibodi
h
hematolog
mixer
fisher
scientif
co
pittsburgh
pa
end
incub
supernat
remov
cell
thoroughli
wash
pb
bsa
three
time
cell
incub
microspher
one
cellfiv
bead
min
hematolog
mixer
remov
unbound
cell
suspens
tube
held
near
dynal
magnet
particl
concentr
minut
suspens
remov
pasteur
pipett
posit
select
cell
complex
microspher
immobil
magnet
field
fac
analysi
type
cell
separ
list
deplet
popul
stain
appropri
mab
singl
label
immunofluoresc
analyz
hewlettpackard
co
palo
alto
ca
facscan
analyt
scanner
neg
select
popul
deplet
ox
either
pan
immunomagnet
separ
result
immunofluoresc
role
irradi
induct
adopt
transfer
sgvhd
current
studi
design
identifi
specif
level
irradi
necessari
manifest
sgvhd
direct
primari
induct
adopt
transfer
induct
studi
lewi
rat
subject
grade
dose
whole
bodi
irradi
follow
infus
syngen
marrow
x
nucleat
cell
treatment
csa
incid
sgvhd
assess
dose
ofradi
lethal
total
bodi
irradi
rad
day
bone
marrow
reconstitut
start
ofcsa
therapi
correl
incid
ofclin
sgvhd
indic
fig
clinic
incid
sgvhd
differ
dose
radiat
recipi
receiv
differ
dose
radiat
either
transfus
x
splenocyt
autoimmun
donor
solid
bar
treat
csa
order
induc
sgvhd
hatch
bar
averag
number
rat
studiedin
group
greater
five
ation
test
ineffect
allow
induct
sgvhd
level
radiat
control
anim
treat
mock
diluent
post
marrow
reconstitut
demonstr
evid
diseas
anim
treat
csa
receiv
irradi
adopt
transfer
studi
lewi
rat
prepar
grade
dose
radiat
follow
infus
splenocyt
anim
activ
sgvhd
togeth
normal
marrow
lethal
subleth
dose
radiat
elicit
high
incid
sever
sgvhd
upon
infus
effector
splenocyt
fig
rad
one
seven
rat
demonstr
clinic
sgvhd
three
anim
exhibit
histolog
sgvhd
lowest
dose
irradi
rad
ineffect
abolish
resist
adopt
transfer
diseas
similarli
infus
effector
splenocyt
nonirradi
anim
transfer
diseas
data
shown
decreas
dose
radiat
correl
reduct
histolog
grade
henc
sever
acut
gvhd
secondari
recipi
treat
rad
demonstr
predomin
grade
three
acut
sgvhd
histolog
anim
clinic
sgvhd
treat
rad
demonstr
histolog
grade
role
prepar
regimen
induct
versu
adopt
transfer
ofautoreact
indic
irradi
integr
compon
gener
autoimmun
precursor
abolish
host
resist
adopt
transfer
prepar
regimen
next
tool
distinguish
individu
characterist
inher
system
use
experiment
design
similar
describ
defin
radiat
sensit
cy
dose
mgkg
combin
subsequ
regimen
ofcsa
ineffect
prepar
regimen
primari
induct
ofsgvhd
shown
fig
howev
cy
dose
mgkg
given
day
adopt
transfer
result
maximum
incid
ofacut
sgvhd
clinic
detect
day
sever
note
patholog
grade
acut
sgvhd
dose
mgkg
drop
grade
acut
sgvhd
mgkg
data
suggest
abolish
host
resist
adopt
transfer
sgvhd
depend
dose
cy
use
tabl
demonstr
busulfan
prepar
regimen
mgkg
day
bone
marrow
rescu
subsequ
csa
therapi
result
induct
sgvhd
low
incid
ofsgvhd
one
eight
rat
occur
concomit
busulfan
cy
therapi
much
later
day
compar
observ
day
irradi
rad
use
abl
therapi
case
adopt
transfer
sgvhd
one
seven
rat
treat
busulfan
treatment
alon
clinic
pictur
acut
sgvhd
also
occur
late
studi
suggest
natur
autoregulatori
system
radiosensit
cy
sensit
rel
busulfan
resist
previou
studi
shown
thymic
irradi
necessari
induct
sgvhd
explor
whether
thymic
irradi
necessari
adopt
transfer
diseas
data
tabl
show
thymic
irradi
collim
beam
focus
thymu
follow
autolog
reconstitut
adopt
transfer
effector
splenocyt
allow
success
transfer
sgvhd
five
ofeight
anim
lower
hemibodi
irradi
allow
transfer
clinic
incid
syngen
gvhd
cy
therapi
recipi
receiv
variou
dose
cy
either
transfus
x
effector
splenocyt
solid
bar
treat
csa
therapi
induc
sgvhd
hatch
bar
averag
number
rat
studi
group
greater
five
fraction
recipi
clinic
gvhd
either
induct
therapi
adopt
transfer
recipi
treat
variou
prepar
regimen
group
b
reconstitut
x
bone
marrow
cell
group
c
underw
autolog
reconstitut
rat
adopt
transfer
studi
receiv
x
splenocyt
autoimmun
donor
sgvhd
data
suggest
thymic
irradi
import
abolit
host
resist
mechan
specif
syndrom
character
theautoregulatori
pbpulat
adopt
cotransf
studi
studi
provid
evid
host
resist
autoregulatori
system
prevent
adopt
transfer
sgvhd
document
character
autoregulatori
cell
seri
adopt
cotransf
studi
perform
two
differ
dose
effector
splenocyt
rat
sgvhd
compar
sinc
potenc
given
effector
popul
predict
variabl
time
csa
withdraw
time
stage
diseas
manifest
inher
differ
capabl
popul
undergo
clonal
expans
explain
vari
potenc
effector
cell
dose
effector
splenocyt
x
capabl
establish
clinic
grade
histolog
sgvhd
irradi
secondari
recipi
tabl
ii
transfer
spleen
cell
reconstitut
noncsatr
rat
mediat
diseas
data
shown
cotransf
x
unfraction
lymphocyt
normal
rat
prevent
establish
sgvhd
recipi
receiv
x
effector
lymphocyt
reduc
clinic
incid
sgvhd
receiv
equival
dose
effector
splenocyt
case
cotransf
normal
unfraction
splenocyt
downregul
histolog
sever
sgvhd
grade
grade
anim
develop
diseas
cotransf
splenocyt
first
fraction
nylon
wool
shown
fag
analysi
x
nylon
woolnonadher
splenocyt
effect
unfraction
splenocyt
reduc
incid
sgvhd
upon
cotransf
equival
number
effector
splenocyt
tabl
ii
cotransf
effector
splenocyt
autoimmun
donor
fraction
unfraction
splenocyt
normal
anim
syngen
marrow
x
cell
effector
splenocyt
x
cell
x
cell
b
x
cell
c
transfus
lethal
irradi
recipi
b
secondari
recipi
receiv
either
splenocyt
x
unfraction
splenocyt
x
nylon
woolnonadher
nwna
splenocyt
normal
anim
c
secondari
recipi
receiv
either
splenocyt
x
nwna
splenocyt
x
nwna
splenocyt
normal
rat
evid
gvhd
tabl
group
clinic
histolog
henc
nylon
woolnonadher
splenocyt
appear
effect
suppress
transfer
diseas
unfraction
splenocyt
tabl
ii
group
c
demonstr
deplet
nylon
woolnonadher
splenocyt
lymphocyt
remov
autoregulatori
effect
present
normal
splenocyt
deplet
protocol
pan
immunomagnet
separ
result
celldeplet
popul
stain
anoth
panspecif
cell
marker
crossreact
cell
type
ie
polymorph
stem
cell
transfer
x
effector
splenocyt
elicit
sgvhd
lethal
irradi
secondari
recipi
cotransf
nylon
wooladher
splenocyt
popul
prevent
transfer
diseas
critic
period
transplant
initi
csa
therapi
adopt
transfer
effector
splenocyt
present
studi
correl
time
initi
daili
csa
therapi
irradi
bone
marrow
transplant
incid
ofclin
patholog
evid
sgvhd
delay
initi
ofcsa
therapi
bone
marrow
transplant
still
result
maximum
incid
sgvhd
csa
treatment
delay
transplant
rat
develop
sgvhd
fig
likewis
time
infus
unfraction
effector
splenocyt
lethal
irradi
secondari
recipi
critic
elicit
complet
transfer
sgvhd
fig
ifeffector
splenocyt
transfer
day
transplant
rat
manifest
sever
gvhd
usual
later
day
bone
marrow
transplant
evid
resist
mechan
clear
sinc
ofth
secondari
recipi
resist
transfer
sgvhd
rat
transplant
compar
pretranspl
rat
absolut
refractori
adopt
transfer
sgvhd
incid
sgvhd
lethal
irradi
recipi
secondari
recipi
receiv
x
effector
splenocyt
prior
irradi
transplant
pre
tx
day
irradi
transplant
number
anim
per
group
four
pathogenesi
sgvhd
remain
unclear
autoaggress
syndrom
repres
disrupt
normal
regener
compet
cell
repertoir
concurr
selftoler
syngen
bone
marrow
transplant
one
ofth
primari
mechan
thought
account
sgvhd
gener
autoreact
cell
recogn
self
mhc
antigen
recent
studi
hess
et
al
shown
develop
sgvhd
associ
induct
cytotox
lymphocyt
direct
public
epitop
class
ii
antigen
gener
self
class
ii
mhc
antigen
reactiv
cell
appear
directli
relat
effect
csa
thymic
function
previou
studi
shown
csa
therapi
irradi
abolish
thymic
medullari
epitheli
cell
caus
reduct
class
ii
antigen
express
irrevers
chang
thought
prevent
normal
mechan
elimin
selfreact
clone
thymic
epitheli
cell
dendrit
cell
known
crucial
educ
ofselfmhc
restrict
henc
microinduct
environ
selftoler
recent
studi
shown
csa
inhibit
intrathym
event
inher
clonal
delet
potenti
interf
cell
receptor
signal
transduct
reduc
class
ii
express
nevertheless
even
normal
anim
presenc
autoreact
cell
peripheri
evid
incomplet
clonal
delet
impli
control
peripher
regulatori
mechan
therefor
peripher
mechan
must
elimin
allow
develop
sgvhd
studi
dispar
drug
radiat
sensit
exemplifi
two
distinct
underli
mechan
gener
autoreact
cell
elimin
host
resist
mechan
first
radiosensit
host
resist
mechan
sensit
induct
mechan
sinc
low
dose
irradi
allow
adopt
transfer
sgvhd
unabl
permit
induct
sgvhd
secondli
cy
dosedepend
fashion
elimin
host
resist
mechan
unabl
trigger
event
essenti
induct
sgvhd
although
cy
inhibit
peripher
regulatori
mechan
surprisingli
ineffect
induc
sgvhd
reveal
possibl
intrins
differ
role
cy
irradi
alter
intrathym
event
essenti
diseas
manifest
also
infer
elimin
ofan
autoregulatori
mechan
insuffici
induct
sgvhd
present
studi
also
suggest
resist
adopt
transfer
distinct
mechan
control
develop
sgvhd
consist
previou
studi
normal
nonirradi
rodent
upon
csa
therapi
alon
fail
manifest
clinic
sign
sgvhd
lymphoid
cell
donor
inflict
sever
autoaggress
transfer
secondari
irradi
recipi
implic
put
autoregulatori
mechan
control
induct
sgvhd
evid
autoregulatori
system
demonstr
adopt
cotransf
studi
nylon
woolnonadher
cell
express
determin
present
matur
lymphocyt
abrog
transfer
establish
sgvhd
everi
effector
splenocyt
transfer
two
unfraction
splenocyt
normal
donor
requir
inhibit
evid
demonstr
autoregulatori
popul
present
normal
anim
ratio
autosuppressor
autoreact
cell
critic
inhibit
ofsgvhd
consist
find
sorokin
et
al
current
studi
focus
analysi
actual
cell
subset
involv
delay
csa
administr
demonstr
initi
transplant
critic
window
initi
csa
therapi
essenti
alter
thymic
microinduct
environ
influenc
gener
selfreact
cell
class
ii
defici
environ
hand
ineffect
effector
splenocyt
transfer
wk
transplant
mediat
sgvhd
demonstr
autoregulatori
arm
appar
reconstitut
within
first
week
bone
marrow
transplant
henc
lethal
irradi
may
critic
abolish
matur
suppressor
mechan
present
either
thymu
andor
peripheri
therefor
effect
ofcsa
therapi
may
relat
gener
effector
cell
may
also
relat
prevent
reconstitut
ofan
autoregulatori
mechan
allow
expans
ofselfreact
cell
synthesi
data
suggest
distinct
mechan
involv
disrupt
immunolog
balanc
autoaggress
autoregulatori
suppress
lead
sgvhd
one
facet
involv
gener
ofautoreact
cell
involv
disrupt
peripher
activ
toler
maintain
mechan
gener
selfreact
cell
singularli
explain
sgvhd
fact
autoreact
cell
capabl
mediat
sgvhd
detect
anim
treat
csa
without
demonstr
clinic
diseas
adopt
transfer
lethal
irradi
recipi
prevent
intrathym
clonal
delet
perturb
autoregulatori
cell
regener
reconstitut
anim
may
determin
factor
diseas
manifest
abolish
autoregul
put
event
creat
permiss
environ
expans
autoreact
cell
subsequ
gener
autoimmun
diseas
previou
studi
suggest
defect
cell
subset
associ
autoimmun
diseas
experiment
anim
support
concept
studi
delin
requir
establish
transfer
sgvhd
show
two
mechan
distinguish
radiat
drug
sensit
exist
b
lethal
irradi
correl
incid
induct
sgvhd
wherea
c
subleth
lethal
irradi
cytoxan
therapi
effect
ablat
host
autoregulatori
system
order
transfer
autoreact
unfraction
well
nylon
woolnonadher
splenocyt
effect
inhibit
transfer
autoimmun
e
deplet
popul
howev
destroy
autoregulatori
effect
present
normal
splenocyt
demonstr
complet
inhibit
immun
reactiv
twice
number
unfraction
splenocyt
normal
anim
requir
everi
splenocyt
autoimmun
donor
last
infus
ofeffector
splenocyt
transplant
correl
decreas
incid
sgvhd
thu
emul
incid
obtain
pretranspl
rat
within
wk
find
clarifi
immunobiolog
complex
sgvhd
suggest
sinc
autoregulatori
cell
alreadi
exist
normal
anim
csainduc
autoimmun
reflect
induc
reactiv
specif
one
therapeut
reagent
uncoupl
normal
immunolog
mechan
essenti
control
autoimmun
